1. Home
  2. AUPH vs NRDS Comparison

AUPH vs NRDS Comparison

Compare AUPH & NRDS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AUPH
  • NRDS
  • Stock Information
  • Founded
  • AUPH 1993
  • NRDS 2009
  • Country
  • AUPH Canada
  • NRDS United States
  • Employees
  • AUPH N/A
  • NRDS N/A
  • Industry
  • AUPH Biotechnology: Pharmaceutical Preparations
  • NRDS EDP Services
  • Sector
  • AUPH Health Care
  • NRDS Technology
  • Exchange
  • AUPH Nasdaq
  • NRDS Nasdaq
  • Market Cap
  • AUPH 1.1B
  • NRDS 616.0M
  • IPO Year
  • AUPH 1999
  • NRDS 2021
  • Fundamental
  • Price
  • AUPH $8.77
  • NRDS $10.98
  • Analyst Decision
  • AUPH Strong Buy
  • NRDS Buy
  • Analyst Count
  • AUPH 2
  • NRDS 6
  • Target Price
  • AUPH $11.50
  • NRDS $15.17
  • AVG Volume (30 Days)
  • AUPH 1.4M
  • NRDS 433.1K
  • Earning Date
  • AUPH 07-31-2025
  • NRDS 07-30-2025
  • Dividend Yield
  • AUPH N/A
  • NRDS N/A
  • EPS Growth
  • AUPH N/A
  • NRDS N/A
  • EPS
  • AUPH 0.27
  • NRDS 0.38
  • Revenue
  • AUPH $247,295,000.00
  • NRDS $734,900,000.00
  • Revenue This Year
  • AUPH $12.15
  • NRDS $18.07
  • Revenue Next Year
  • AUPH $18.31
  • NRDS $8.22
  • P/E Ratio
  • AUPH $31.76
  • NRDS $28.95
  • Revenue Growth
  • AUPH 29.20
  • NRDS 24.20
  • 52 Week Low
  • AUPH $5.20
  • NRDS $7.55
  • 52 Week High
  • AUPH $10.67
  • NRDS $16.45
  • Technical
  • Relative Strength Index (RSI)
  • AUPH 66.00
  • NRDS 54.62
  • Support Level
  • AUPH $7.71
  • NRDS $10.45
  • Resistance Level
  • AUPH $8.29
  • NRDS $11.14
  • Average True Range (ATR)
  • AUPH 0.25
  • NRDS 0.33
  • MACD
  • AUPH 0.03
  • NRDS -0.04
  • Stochastic Oscillator
  • AUPH 84.40
  • NRDS 56.13

About AUPH Aurinia Pharmaceuticals Inc

Aurinia Pharmaceuticals Inc is a biopharmaceutical company focused on delivering therapies to people living with autoimmune diseases with high unmet medical needs. The company developed LUPKYNIS (voclosporin), the first FDA-approved oral therapy for the treatment of adult patients with active lupus nephritis. It is also developing AUR200, a dual inhibitor of B cell activating factor (BAFF) and a proliferation-inducing ligand (APRIL), for the potential treatment of autoimmune diseases.

About NRDS NerdWallet Inc.

Nerdwallet Inc is a company that provides onsumer-driven advice about personal finance through its platform by connecting individuals and small and mid-sized businesses (SMBs) with providers of financial products. It gets revenue from fees paid by its financial services partners in the form of either revenue per action, revenue per click, revenue per lead and revenue per funded loan arrangements.

Share on Social Networks: